Description
A cell-permeable benzoxazolo-sulfonamide compound that blocks human FBPase-1 enzymatic activity by competing at the AMP allosteric binding site (IC50 = 3.4 µM; Ki = 1.1 µM); blocks glucose production in starved rat hepatoma cells (IC50 = 6.6 µM)
Formal name: 2,5-dichloro-N-(5-chloro-2-benzoxazolyl)-benzenesulfonamide
Synonyms: F1,6BPase-1 Inhibitor|FBP1 Inhibitor|FBPase-1 Inhibitor
Molecular weight: 377.6
CAS: 883973-99-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Phosphatases||Research Area|Endocrinology & Metabolism|Carbohydrate Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes